AKT1 and cancer: KEGG pathway enrichment analysis identified 199 pathways (adjusted p < 0.05), mainly involving AGE-RAGE signaling in diabetic complications, lipids and atherosclerosis, endocrine resistance, steroid hormone biosynthesis, PI3K-Akt and various cancer-related pathways.